5VND | Transferase Transferase Inhibitor | date | Apr 30, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Fgfr1-Y563c (Fgfr4 Surrogate) Covalentl H3b-6527 | ||||||||||||||
authors | J.H.C.Tsai, D.Reynolds, P.Fekkes, P.Smith, N.A.Larsen | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Fibroblast Growth Factor Receptor 1 Chain: A, B Fragment: Unp Residues 458-765 Synonym: Fgfr-1,Basic Fibroblast Growth Factor Receptor 1,B Fms-Like Tyrosine Kinase 2,Flt-2,N-Sam,Proto-Oncogene C-Fgr Ec: 2.7.10.1 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Fgfr1, Bfgfr, Cek, Fgfbr, Flg, Flt2, Hbgfr Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: De3 Star | ||||||||||||||
symmetry | Space Group: C 1 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.20 Å | ||||||||||||
ligand | 9ES, EDO, SO4 | enzyme | Transferase E.C.2.7.10.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma., Joshi JJ, Coffey H, Corcoran E, Tsai J, Huang CL, Ichikawa K, Prajapati S, Hao MH, Bailey S, Wu J, Rimkunas V, Karr C, Subramanian V, Kumar P, MacKenzie C, Hurley R, Satoh T, Yu K, Park E, Rioux N, Kim A, Lai WG, Yu L, Zhu P, Buonamici S, Larsen N, Fekkes P, Wang J, Warmuth M, Reynolds DJ, Smith PG, Selvaraj A, Cancer Res. 2017 Dec 15;77(24):6999-7013. doi: 10.1158/0008-5472.CAN-17-1865. PMID:29247039 |
Data retrieval |
View 5VND in 3D |
Visual 3D analysis of 5VND |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5VND |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |